Metabolic phenotyping and systems biology approaches to understanding metabolic syndrome and fatty liver disease.
about
Gut Microbiota Profiling: Metabolomics Based Approach to Unravel Compounds Affecting Human HealthThe Pathogenesis of Nonalcoholic Fatty Liver Disease: Interplay between Diet, Gut Microbiota, and Genetic BackgroundUtilization of animal models to investigate non-alcoholic steatohepatitis-associated hepatocellular carcinomaThe contributory role of gut microbiota in cardiovascular diseaseMagnetic Resonance Spectroscopy: Principles and Techniques: Lessons for CliniciansFunctional metabolomics: from biomarker discovery to metabolome reprogrammingTwo elephants in the room: new hybrid nuclear magnetic resonance and mass spectrometry approaches for metabolomicsMetabolomic analysis to define and compare the effects of PAHs and oxygenated PAHs in developing zebrafishCystic fibrosis related liver disease--another black box in hepatology.4Ps medicine of the fatty liver: the research model of predictive, preventive, personalized and participatory medicine-recommendations for facing obesity, fatty liver and fibrosis epidemics.Metabolomic analysis shows differential hepatic effects of T2 and T3 in rats after short-term feeding with high fat diet.Urinary Metabolomics in Pediatric Obesity and NAFLD Identifies Metabolic Pathways/Metabolites Related to Dietary Habits and Gut-Liver Axis Perturbations.Microbial-Host Co-metabolites Are Prodromal Markers Predicting Phenotypic Heterogeneity in Behavior, Obesity, and Impaired Glucose ToleranceFar from the eyes, close to the heart: dysbiosis of gut microbiota and cardiovascular consequences.Description and prediction of the development of metabolic syndrome in Dongying City: a longitudinal analysis using the Markov model.The emergence of proton nuclear magnetic resonance metabolomics in the cardiovascular arena as viewed from a clinical perspectiveModules, networks and systems medicine for understanding disease and aiding diagnosis.CDKAL1-related single nucleotide polymorphisms are associated with insulin resistance in a cross-sectional cohort of Greek children.A study of the effects of exercise on the urinary metabolome using normalisation to individual metabolic output.Effects of high fructose and salt feeding on systematic metabonome probed via (1) H NMR spectroscopy.Systems biology of host-microbe metabolomics.The promise of metabolic phenotyping in gastroenterology and hepatology.The genetic architecture of NAFLD among inbred strains of miceCohort profile: LifeLines DEEP, a prospective, general population cohort study in the northern Netherlands: study design and baseline characteristics.The metabolic role of the gut microbiota in health and rheumatic disease: mechanisms and interventions.Establishment of Protocols for Global Metabolomics by LC-MS for Biomarker DiscoveryMitochondrial gene polymorphisms alter hepatic cellular energy metabolism and aggravate diet-induced non-alcoholic steatohepatitis.Association of Non-alcoholic Fatty Liver Disease with Metabolic Syndrome Independently of Central Obesity and Insulin Resistance.Plasma Trimethylamine N-Oxide, a Gut Microbe-Generated Phosphatidylcholine Metabolite, Is Associated With Atherosclerotic BurdenSerum metabolome profiles characterized by patients with hepatocellular carcinoma associated with hepatitis B and C.Personal model-assisted identification of NAD+ and glutathione metabolism as intervention target in NAFLD.LC-MS-based metabolomics: an update.Antibiotics/antimicrobials: systemic and local administration in the therapy of mild to moderately advanced periodontitis.Roux-en-Y Gastric Bypass.Serum metabolomic profiling highlights pathways associated with liver fat content in a general population sample.Nodes with high centrality in protein interaction networks are responsible for driving signaling pathways in diabetic nephropathy.Recovery of pan-genotypic and genotype-specific amino acid alterations in chronic hepatitis C after viral clearance: transition at the crossroad of metabolism and immunity.Novel insights into development of diabetic bladder disorder provided by metabolomic analysis of the rat nondiabetic and diabetic detrusor and urothelial layer.Urinary (1)H-NMR-based metabolic profiling of children with NAFLD undergoing VSL#3 treatment.Metabolic phenotyping for enhanced mechanistic stratification of chronic hepatitis C-induced liver fibrosis.
P2860
Q26738283-B08449F9-ABE8-41CA-92EA-A8D49951E5CEQ26744380-D220D5C7-78E1-4C90-8420-EBF39293872BQ26748807-12884BF1-C1EA-4D48-A261-EDB93D928201Q26830828-6884C43E-C51B-4923-96B8-1FA1B51C90F9Q28066771-38387D1C-8104-4DD5-A157-E3B059BFA048Q28610979-BB03CAD2-3657-49F9-951A-8145AFD886C0Q28611329-E3E25354-D626-480C-978D-7688CD3E566EQ28647503-B798D564-12BE-4846-A0BB-4F056384DF3FQ28655881-0A2FB24E-565D-4D75-81E9-96A9525AC450Q30412771-1EF3ECAD-7C85-4D38-8C16-5F48C626CDCBQ33700432-E7F7EE2C-CD92-44D4-80A8-3D7BB2BBE931Q33749444-DB9BE314-8D60-4197-BFA0-03C303D26C2FQ33899037-4BAFB6C8-8EF1-43AA-99D0-AB0439CBC4F5Q34324267-745EAB19-2EC6-4A63-B0F2-1D939BF34FC3Q34401940-7D837D79-C597-4CD6-BA4A-07BAE364F713Q34513438-B3CA05DC-437D-43C5-BDDB-010D6550911BQ34624769-EA56A838-BE03-4BAA-A2EB-FFDDB61C90F9Q35138416-B9219EDD-7D5B-4E6B-B069-D64584B7614BQ35237607-8CCFF371-4810-401B-9354-F8F3CD6FB8FAQ35553116-DECBBF4E-E1BD-4B93-98B8-20BE48B83BF0Q35619563-CFE3683A-F9F1-424B-B02E-2ECF7C2EB974Q35701279-2A419BBB-92D7-45D8-B12E-4F5C2A3DF3C4Q35825098-1777CA75-59A3-4F52-8AE8-2D9F603BFF37Q36011711-068A38CC-8439-42B3-A0F2-7A081D830E64Q36038992-88CDB184-3736-426E-96DE-6CB276516678Q36118501-14CEFF7F-4996-4014-90DE-08D2D5D16EA0Q36740555-01979EC1-C850-4EAE-8A87-C4A28B9B824BQ36953626-792328CB-C545-4876-A0B8-080C91669EB8Q36968992-E2D996F5-90D8-46C5-86F9-822F367CC880Q37096702-05C68E3A-276A-4925-A7C2-F999F4BD3090Q37727707-14FFE805-109E-4DAC-9131-813A7D29FB7CQ38202881-C1ED31A7-FDAF-4A0E-88E8-FC15B5A3D08BQ38798347-5A306B10-D340-4316-A84D-11A7FCDFD411Q38960941-CDC3336B-8E4D-4BAD-9DB4-18BC056C5A41Q40257413-515B6524-4E39-42D4-BB43-0D229660DE27Q40334436-F5FA8E5F-3A38-496E-B624-288B061F2A2BQ40481684-208039BA-5030-40CD-B553-A2CA7CFFF291Q40982063-8121498B-AC99-45D1-A86F-4B07E7F39A9DQ41158897-E92F3761-B6DC-49F9-B625-F1EB87B6B479Q41658253-ECDC60B8-1927-45DA-ACA0-2AED78F2C96B
P2860
Metabolic phenotyping and systems biology approaches to understanding metabolic syndrome and fatty liver disease.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Metabolic phenotyping and syst ...... drome and fatty liver disease.
@en
type
label
Metabolic phenotyping and syst ...... drome and fatty liver disease.
@en
prefLabel
Metabolic phenotyping and syst ...... drome and fatty liver disease.
@en
P50
P1433
P1476
Metabolic phenotyping and syst ...... drome and fatty liver disease.
@en
P356
10.1053/J.GASTRO.2013.11.001
P407
P577
2013-11-07T00:00:00Z